| | | C<sub>11</sub>H<sub>12</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | | | | | | <a href="PDF/P_InfoEn/C-032.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/C-032.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/C-032.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/C-032.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>18</sub>H<sub>36</sub>-<sub>37</sub>N<sub>45</sub>O<sub>10</sub>-<sub>11</sub>.H<sub>2</sub>SO<sub>4</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | kanamycin monosulfate; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine sulfate (1:1) (salt). | Antibacterial agent similar to neomycin. This substance is a mixture of many individual substances and cannot be adequately represented by a single molecular structure.
Cross: neomycin, streptomycin, gentamicin sulfate, dihydrostreptomycin. | | | | <a href="PDF/P_InfoEn/K-001.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/K-001.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/K-001.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/K-001.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | (C<sub>20</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>)<sub>2</sub>-.H<sub>2</sub>SO<sub>4</sub>.<sub>2</sub>H<sub>2</sub>O | | | | | | <img src="../IMAGES/pet.gif"/> | Quinine sulfate (2:1), dihydrate. | Antimalarial agent also used as antipyreticum and in liquids (tonic etc.).PA | | | | <a href="PDF/P_InfoEn/Q-001.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/Q-001.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/Q-001.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/Q-001.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>6</sub>H<sub>8</sub>N<sub>2</sub>O<sub>2</sub>S | | | | | | <img src="../IMAGES/pet.gif"/> | Bacteramid; p-Aminobenzenesulfonamide; 4-Aminobenzenesulfonamide; p-Anilinesulfonamide; p-Sulfamidoaniline; 1162 F; Albexan; Deseptyl; Prontalbin; Prontosil album; Prontylin; Septoplix; Streptocid album; Streptocide; AVC; Vagitrol; Sulfonamide; Sulfanilimide; p-aminobenzenesulfamide; p-aminophenylsulfonamide; aniline-p-sulfonic amide; albosal; ambeside; antistrept; astreptine; astrocid; bactesid; collomide; colsulanyde; copticide; dipron; ergaseptine; erysipan; estreptocida; F 1162; fourneau 1162; gerison; gombardol; Lusil; lysococcine; neococcyl; orgaseptine; PABS; prontosil albom; prontosil i; prontosil white; pronzin album; proseptal; proseptine; proseptol; pysococcine; rubiazol a; sanamid; septamide album; septanilam; septinal; septolix; septoplex; stopton album; stramid; strepamide; strepsan; streptagol; streptamid; streptasol; streptoclase; streptocom; streptol; strepton; streptosil; streptozol; streptozone; streptrocide; sulfamidyl; sulfamine; sulfana; sulfanalone; sulfanil; sulfocidine; sulfonamide p; therapol; Aminobenzenesulfonamide. | Antibacterial agent and antimicrobial agent of sulfonamide type (topical and vaginal). Cross:(photo) para group of compounds. May produce erythema multiforme like eruptions. PA. PL | | | | <a href="PDF/P_InfoEn/S-010.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/S-010.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/S-010.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/S-010.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>19</sub>-<sub>21</sub>H<sub>39</sub>-<sub>43</sub>N<sub>5</sub>O<sub>7</sub>.<sub>2</sub>.<sub>5</sub>H<sub>2</sub>SO<sub>4</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | Jenamicin; Gentamicin sulfate; Alcomicin; Bristagen; Cidomycin; Duragentam; Garasol; Genoptic; Gentacin; Gentamycin sulfate; Gentocin; Gentogram; Gentalyn; Gentibioptal; Gent-Ophtal; Lugacin; Nichogencin; Ophtagram; Pangram; Refobacin; Septopal; Sulmycin; U-gencin; Gentaglyde; Gentamex 100; Gentacidin; genoptic s.o.p.; gm sulfate; getalline; genticin; sch 9724; Gentamicin C Complex Citrate. | Topical and systemic broad-spectrum antibiotic with bactericidal action. Also used in ophthalmic drugs. This compound is a complex mixture of the sulfates of gentamycin C1, gentamycin C1A and gentamycin C2. Pharmaceutical incompatibilites include amphotericin, cephalosporins, erythromycin, heparin, penicillins, sodium bicarbonate and sulfadiazine sodium [295]. ICU. Cross: neomycin sulfate | | | | <a href="PDF/P_InfoEn/G-006.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/G-006.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/G-006.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/G-006.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>6</sub>H<sub>6</sub>N<sub>4</sub>O<sub>4</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | 5-Nitro-2-furaldehyde Semicarbazone; Nitrofural; 2-[(5-Nitro-2-furanyl)methylene]-hydrazinecarboxamide; Aldomycin; Amifur; Chemofuran; Coxistat; Furacin; Furesol; Mammex; Nifuzon; Nitrorural; Nitrozone; Furacinetten; Furacoccid; Furazol W; Furaplast; Nefco; Vabrocid; NFZ; nitrofuraldehyde semicarbazone; 5-nitrofuraldehyde semicarbazide; 6-nitrofuraldehyde semicarbazide; (5-nitro-2-furfurylideneamino)urea; alfucin; babrocid; becafurazone; biofuracina; biofurea; chixin; cocafurin; dermofural; dyanazone; eldezol; eldezol f-6; fedacin; flavazone; fracine; furacilin; furacillin; furacin-hc; furacort; furacycline; furaldon; furalone; furametral; furan-ofteno; furaseptyl; furaskin; furaziline; furazin; furazina; furazone; furfurin; furosem; fuvacillin; hemofuran; ibiofural; mastofuran; monofuracin; NF; NF-7; NFS; nifucin; nifurid; 5-nitrofuran-2-aldehyde semicarbazone; 5-nitro-2-furancarboxaldehyde semicarbazone; nitrofurazan; 5-nitro-2-furfuraldehyde semicarbazone; 5-nitrofurfural semicarbazone; 5-nitro-2-furfural semicarbazone; otofuran; sanfuran; spray-dermis; spray-foral; U-6421; vadrocid; veterinary nitrofurazone; yatrocin; 2-furaldehyde, 5-nitro-, semicarbazole; 5-Nitro-2-furfurylidene semicarbazone. | This compound is used as a topical anti-infective and as a bactericide for most pathogens commonly causing surface infections. If is also used in the adjunctive therapy of patients with second and third degree burns when bacterial resistance to other agents is a real or potential problem. It is also indicated in skin grafting where bacterial contamination may cause graft rejection and/or donor site infection. It is also an antibacterial agent for the treatment or prevention of infections in a variety of conditions involving skin, eyes, ears, nose and genito-urinary tract. It is used on pyodermas, ulcers and wounds. This chemical affects some protozoa and is an effective prophylaxis against nosocomial infections. It is used as an antiseptic lubricant for transurethral resection. It is also used as an anti-microbial in veterinary medicine. ABCD. | | | | <a href="PDF/P_InfoEn/N-005.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/N-005.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/N-005.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/N-005.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>66</sub>H<sub>103</sub>N<sub>17</sub>O<sub>16</sub>S | | | | | | <img src="../IMAGES/pet.gif"/> | Agfivin; Altracin; Ayfivin; Baciquent; Fortracin; Penitracin; Topitracin; Zutracin; Citracin. | Antibiotic agent effective against gram-positive organisms and spirochetes. In products for topical treatment, ear medications and ophthalmic drugs. Common allergen in leg ulcer treatment. May cause systemic contact type dermatitis. Cross: polymyxin B sulfate, neomycin sulfate. ICU | | | | <a href="PDF/P_InfoEn/B-032A.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/B-032A.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/B-032A.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/B-032A.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | | Framycetin sulfate/(Neomycin B) | | | | | <img src="../IMAGES/pet.gif"/> | D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy.
Neomycin B,Framycetin,
Soframycin,NSC156885 (SULFATE) | Framycetin, a broad spectrum aminoglycoside antibiotic, is usually bactericidal in action.
For local use in the treatment of infections caused by pyogenic organisms, in particular S. aureus, the proteus group of bacteria, coliforms and P. aeruginosa.
Ointment: The treatment of bacterial infections of the skin and mucous membrane caused by susceptible bacteria. These include such conditions as pyoderma, folliculitis, paronychia, sycosis barbae, and impetigo. Also useful in controlling secondary bacterial infections in skin carcinoma, burns, eczemas, contact dermatitis, seborrhea, acne, psoriasis, varicose ulcers, and neurodermatitis.
Ophthalmic Drops and Ointment: Treatment of bacterial blepharitis, conjunctivitis, styes, corneal abrasions and burns; prophylactically following removal of foreign bodies; corneal ulcers (sole treatment or as an adjunct to subconjunctival injection of framycetin). | | | | <a href="PDF/P_InfoEn/F-005.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/F-005.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/F-005.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/F-005.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | | | | | | | <img src="../IMAGES/pet.gif"/> | Mix of substances used as local or topical anesthetic agents or in dentistry. | | | | | <a href="PDF/P_InfoEn/MX-19.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/MX-19.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/MX-19.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/MX-19.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>18</sub>H<sub>14</sub>Cl<sub>4</sub>N<sub>2</sub>O | | | | | | <img src="../IMAGES/aq.gif"/> | 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole; 1-[2,4-dichloro-b-[(2,4-dichlorobenzyl)oxy]phenethyl]imidazole; Fungisdin; Aflorix; Albistat; Andergin; Brentan; Conoderm; Conofite; Daktar; Daktarin; Deralbine; Dermonistat; Epi-Monistat; Florid; Gyno-Daktarin; Gyno-Monistat; Micatin; miconal Ecobi; Monistat; Prilagin; Vodol. | Antifungal agent of the imidazole type which is used in topical and vaginal preparations to prevent growth of
dermatophytes, yeast and molds. Cross: econazole, enilconazole. | | | | <a href="PDF/P_InfoEn/M-027.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/M-027.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/M-027.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/M-027.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>18</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>4</sub> | | | | | | <img src="../IMAGES/aq.gif"/> | r 14,827; Ecostatin; Epi-Pevaryl; Gyno-prevaryl; Ifenec; Micofugal; Micogin; Palavale; Pargin; Pevaryl; Spectazole; 1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole nitrate; 1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole mononitrate; 1-(2,4-dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)imidazole nitrate; 1-(2,4-dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)imidazole mononitrate. | Antifungal agent of the imidazole type used in topical and vaginal preparations to prevent growth of dermatophytes, yeast, and mold. Cross: miconazole, enilconazole. May produce erythema multiforme like eruptions. | | | | <a href="PDF/P_InfoEn/E-021.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/E-021.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/E-021.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/E-021.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | | | | | | | <img src="../IMAGES/pet.gif"/> | Mix of substances used as local or topical anesthetic agents or in dentistry. | | | | | <a href="PDF/P_InfoEn/MX-20.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/MX-20.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/MX-20.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/MX-20.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>31</sub>H<sub>47</sub>NaO<sub>6</sub> | | | LU-2,ME-13, NAE65-62, NAC80-68 | | | <img src="../IMAGES/pet.gif"/> | | | | | | <a href="PDF/P_InfoEn/F-003.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/F-003.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/F-003.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/F-003.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>16</sub>H<sub>13</sub>Cl<sub>3</sub>N<sub>2</sub>OS | | | | | | <img src="../IMAGES/pet.gif"/> | | | | | | <a href="PDF/P_InfoEn/T-034.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/T-034.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/T-034.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/T-034.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>18</sub>H<sub>37</sub>N<sub>5</sub>O<sub>9</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | | This substance is an aminoglycoside antibiotic derived from Streptomyces tenebrarius and used to treat various types of bacterial infections, particularly Gram-negative infections. | | | | <a href="PDF/P_InfoEn/T-050.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/T-050.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/T-050.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/T-050.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>66</sub>H<sub>75</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>24</sub>·HCl | | | | | | <img src="../IMAGES/aq.gif"/> | | This substance is an antibiotic used to treat a number of bacterial infections. It is used as a first-line treatment for complicated skin infections, bloodstream infections, endocarditis, bone and joint infections, and meningitis caused by methicillin-resistant S. Aureus. | | | | <a href="PDF/P_InfoEn/V-004.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/V-004.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/V-004.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/V-004.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>12</sub>H<sub>17</sub>NO<sub>3</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | | Drug used as an anti-inflammatory agent on the skin, as well as rectally. Ointments and lotions containing bufexamac are used for the treatment of subacute and chronic eczema of the skin, including atopic eczema, as well as sunburn and other minor burns, and itching. Suppositories containing bufexamac in combination with local anaesthetics are used against haemorrhoids. | | | | <a href="PDF/P_InfoEn/B-043.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/B-043.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/B-043.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/B-043.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>17</sub>H<sub>27</sub>NO<sub>3</sub>-HCI | | | | | | <img src="../IMAGES/pet.gif"/> | Pramocaine, Pramocaine HCI, p-n butoxyphenyl gammamorpholinopropyl ether hydrochloride | Pramoxine is a topical anesthetic and used as an antipruritic. Like other local anesthetics, Pramoxine decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses. Depolarization and repolarization of excitable neural membranes is thus inhibited, leading to numbness. The hydrochloride salt form of Pramoxine is water-soluble. | | | | <a href="PDF/P_InfoEn/P-039.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/P-039.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/P-039.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/P-039.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>19</sub>H<sub>20</sub>N<sub>2</sub>O<sub>2</sub> | | | | | | <img src="../IMAGES/pet.gif"/> | Fenilbutazona; Butazolidin, Diphenylbutazone, 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione | An anti-inflammatory agent with antipyretic and analgesic activities. It is used in the treatment of ankylosing spondylitis and rheumatoid arthritis. In some countries the drug is only approved for use in veterinary medicine. | | | | <a href="PDF/P_InfoEn/P-041.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/P-041.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/P-041.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/P-041.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C<sub>17</sub>H<sub>22</sub>ClNO | Diphenhydramine hydrochloride | | | | | <img src="../IMAGES/pet.gif"/> | Benadryl; O-benzhydryldimethylaminoethanol; b-Dimethylaminoethanol diphenylmethyl ether; a-(2-dimethylaminoethoxy)diphenylmethane; Benzhydramine; Alledryl; Allergin; Amidryl; Bagodryl; benodin; Benylan; Benzantin; Dibendrin; Dibondrin; Dihidral; Diphantine; S 8; Sekundal-D; Syntedril; BAX; Benocten; Benzehist; Dabylen; Dolestan; Felben; Fenylhist; Halbmond; Rohydra; Sedopretten; Valdrene; Wehydryl; Ambenyl; Benylin; Hydryllin; 2-(benzhydryloxy)-N,N-dimethylethylamine hydrochloride; 2-diphenylmethoxy-N,N-dimethylethylamine hydrochloride; dimethylamine benzhydryl ester hydrochloride; beta-dimethylaminoethyl benzhydryl ether hydrochloride; alpha-hydroxydiphenylmethane-beta-dimethylaminoethyl ether hydrochloride; 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride; N,N-dimethyl-2-(diphenylmethoxy)ethylamine hydrochloride; 2-benzhydryloxyethyl-N,N-dimethylammonium chloride; BENA; benadryl hydrochloride; bendylate; benzhydramine hydrochloride; difenhydramine hydrochloride; dimedrol; eldadryl; sk-diphenhydramine; allergan; allergival; denydryl; diphenylhydramine hydrochloride; resmin; restamin; VENA. | This compound is used as an antihistamine and for its anticholinergic (drying) and sedative effects. It is also used for allergic conjunctivitis due to foods, for mild, uncomplicated allergic skin manifestations of urticaria and angioedema, for amelioration of allergic reactions to blood or plasma, for dermatographism, in therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled, for active and prophylactic treatment of motion sickness and for parkinsonism. It is used as an antiemetic and has local anesthetic properties. This compound is also used in preparations for the relief of cough and in the prevention and treatment of radiation sickness, nausea and vomiting. Also used for treatment of allergic cheilitis and stomatitis. PA | | | | <a href="PDF/P_InfoEn/D-021.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/D-021.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/D-021.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/D-021.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |
| | | C55-56H96-98N16-O13-.2H2SO4 | | | | | | <img src="../IMAGES/pet.gif"/> | Aerosporin. Neomycin sulfate is the sulfate salt of neomycin B and C, which are produced by the growth of Streptomyces fradiaeWaksman (Fam.Streptomycetaceae). It has a potency equivalent of not less than 600 mcg of neomycin standard per mg, calculated on an anhydrous basis. | Topical antibiotic agent widely used, often in combination with neomycin. Polymyxin B is an important allergen in leg ulcer dermatitis. Products include ointments, creams, eye and ear drops.
Cross: bacitracin. | | | | <a href="PDF/P_InfoEn/P-026.pdf" Target="_blank">English</a> | <a href="PDF/P_InfoFr/P-026.pdf" Target="_blank">French</a> | <a href="PDF/P_InfoSp/P-026.pdf" Target="_blank">Spanish</a> | <a href="PDF/MSDS/P-026.pdf" Target="_blank">SDS</a> | <a href="PDF/TestFrm/ME-1000.pdf" Target="_blank">English</a> | <a href="PDF/TestFrm/Prev/ME-1000.pdf" Target="_blank">Previous Year</a> | |